Cancer mortality in young adults in Switzerland, 1951-1989
- PMID: 1890144
- PMCID: PMC12200482
- DOI: 10.1007/BF01612774
Cancer mortality in young adults in Switzerland, 1951-1989
Abstract
Trends in mortality from all neoplasms and major cancer sites in Switzerland among populations aged between 20 and 44 years are presented. In men total cancer mortality was approximately constant around 270/10(6) between 1951 and 1965, but declined appreciably thereafter to 217 per million in 1980-1989. The overall fall was 20%. The pattern of trends was similar for women, although a modest decline was already apparent in the earlier calendar period, and the overall fall was 29% (from 303 to 215/10(6)). These favourable trends reflect therapeutic advancements for Hodgkin's disease, leukaemias, testis and (chiefly non-epithelial) ovarian cancer, better control of cervical cancer, the long-term decline in gastric cancer, but also the downward trends in cancer of the intestines and a few less common sites, such as gallbladder and thyroid neoplasms for reasons that are not yet clear. Appreciable rises were observed for lung and other tobacco-related sites in women, for the oral cavity in men and (in earlier calendar periods) cutaneous melanoma in both sexes. Although restricted to a selected number of sites, these rises are discouraging, since the causes of these neoplasms have long been recognized. Somewhat discouraging also is the absence of decline in male lung cancer. These problems notwithstanding, the overall pattern of trends in cancer mortality in young Swiss adults over the last few decades is still reassuring, particularly in comparison with those observed in other European countries, and in the more general framework of the debate on the perspectives of progress in cancer control. Although restricted to a small proportion of all cancer deaths, in fact, trends in young adults offer useful indications on the likely future trends in the same generations in the near future, since they reflect more recent changes in the pattern of exposure. The size of the changes, however, will probably differ, since the prevalent cancers in middle age are different from those in the young.
Similar articles
-
The application of age, period and cohort models to predict Swiss cancer mortality.J Cancer Res Clin Oncol. 1990;116(2):207-14. doi: 10.1007/BF01612679. J Cancer Res Clin Oncol. 1990. PMID: 2324165 Free PMC article.
-
The Black Book of Psychotropic Dosing and Monitoring.Psychopharmacol Bull. 2024 Jul 8;54(3):8-59. Psychopharmacol Bull. 2024. PMID: 38993656 Free PMC article. Review.
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Cancer mortality in young adults: Italy 1955-1985.J Cancer Res Clin Oncol. 1990;116(2):215-9. doi: 10.1007/BF01612680. J Cancer Res Clin Oncol. 1990. PMID: 2324166 Free PMC article.
-
All-Cause Mortality and Specific Causes of Death in Autism: A Nationwide Analysis.Autism Adulthood. 2025 Feb 5;7(1):81-92. doi: 10.1089/aut.2023.0103. eCollection 2025 Feb. Autism Adulthood. 2025. PMID: 40151655
Cited by
-
Trends in cancer of the cervix uteri in Sweden following cytological screening.Br J Cancer. 1999 Sep;81(1):159-66. doi: 10.1038/sj.bjc.6690666. Br J Cancer. 1999. PMID: 10487628 Free PMC article.
References
-
- Boyle P (1989) Relative value of incidence and mortality data in cancer research. In: Boyle P, Muir CS, Grundmann (eds) Cancer mapping. Recent Results Cancer Res 114:41–63 - PubMed
-
- Boyle P, Zaridze DG, Smans M (1985) Descriptive epidemiology of colorectal cancer. Int J Cancer 36:9–18 - PubMed
-
- Bundesamt für Statistik (1984) Krebssterblichkeit: QualitÄt der Daten in der Schweiz. BeitrÄge zur schweizerischen Statistik, 125, Bundesamt für Statistik, Bern
-
- Davis DL, Hoel D, Fox J, Lopez A (1990) International trends in cancer mortality in France, West Germany, Italy, Japan, England and Wales, and the USA. Lancet 336:474–481 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources